FDA issued a Warning Letter to Cantrell Drug Company on 1/21/2015 as a result of this inspection.
483 Cantrell Drug Company Nov 2013

483 Cantrell Drug Company Nov 2013

Elizabeth Connell FDA, Torrance Slayton FDA$119.00 - Available Now

FDA investigators audited the Cantrell Drug Company - Little Rock, AR, United States facility and issued 12 inspectional observations (via FDA 483) on 04 Nov 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 12
  • Inspection end: 04 Nov 2013
  • Location: Little Rock, United States
  • FEI: 3004483441
Add To Cart